Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling.
Angus L, Smid M, Wilting SM, Bos MK, Steeghs N, Konings IRHM, Tjan-Heijnen VCG, van Riel JMGH, van de Wouw AJ, Cpct Consortium, Cuppen E, Lolkema MP, Jager A, Sleijfer S, Martens JWM. Angus L, et al. Among authors: smid m. Cancers (Basel). 2023 Sep 4;15(17):4416. doi: 10.3390/cancers15174416. Cancers (Basel). 2023. PMID: 37686693 Free PMC article.
Genes associated with breast cancer metastatic to bone.
Smid M, Wang Y, Klijn JG, Sieuwerts AM, Zhang Y, Atkins D, Martens JW, Foekens JA. Smid M, et al. J Clin Oncol. 2006 May 20;24(15):2261-7. doi: 10.1200/JCO.2005.03.8802. Epub 2006 Apr 24. J Clin Oncol. 2006. PMID: 16636340
CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer.
van Agthoven T, Sieuwerts AM, Veldscholte J, Meijer-van Gelder ME, Smid M, Brinkman A, den Dekker AT, Leroy IM, van Ijcken WF, Sleijfer S, Foekens JA, Dorssers LC. van Agthoven T, et al. Among authors: smid m. Br J Cancer. 2009 Dec 1;101(11):1824-32. doi: 10.1038/sj.bjc.6605423. Epub 2009 Nov 10. Br J Cancer. 2009. PMID: 19904269 Free PMC article.
MicroRNA-30c expression level is an independent predictor of clinical benefit of endocrine therapy in advanced estrogen receptor positive breast cancer.
Rodríguez-González FG, Sieuwerts AM, Smid M, Look MP, Meijer-van Gelder ME, de Weerd V, Sleijfer S, Martens JW, Foekens JA. Rodríguez-González FG, et al. Among authors: smid m. Breast Cancer Res Treat. 2011 May;127(1):43-51. doi: 10.1007/s10549-010-0940-x. Epub 2010 May 19. Breast Cancer Res Treat. 2011. PMID: 20490652
393 results